Loading insider details...
Latest Form 4 (Mar 2, 2026): Grant/Award of 29,561 GENB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 2, 2026 | Generate Biomedicines, Inc. (GENB) | Grant/Award | 29,561 | n/a |
| Dec 4, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Sale | 37,070 | $10.0K |
| Nov 27, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Sale | 134,713 | $35.7K |
| Nov 4, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 40,125 | n/a |
| Jun 7, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Grant/Award | 4,000 | n/a |
| Apr 2, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 6,000 | n/a |
| Dec 5, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Disposition to Issuer | 7,500 | n/a |
| Nov 2, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 40,125 | n/a |
| Apr 4, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 6,000 | n/a |
| Feb 21, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Grant/Award | 118,700 | n/a |